focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS UPDATES: Kitwave hails rise in annual revenue and profit

Tue, 28th Feb 2023 14:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Kitwave Group PLC - North Shields, England-based food wholesaler - Posts revenue of GBP503.1 million for the year ended on October 31, up 32% from GBP380.7 million the year before. Pretax profit surges to GBP17.8 million from GBP2.1 million, as operating profit jumps to GBP20.4 million from GBP6.4 million the year before. Adjusted earnings before interest, tax, depreciation and amortisation amounts to GBP29.5 million, compared t GBP15.1 million the year earlier. Finance expenses reduce to GBP2.5 million from GBP4.3 million. Kitwave says it is recommending a final dividend of 6.75 pence each, subject to approval. If approved, this would take the total dividend for the financial year to 9.25 pence, up 37% from 6.75p a year prior. Looking ahead, Kitwave expects a positive outcome for financial 2023.

----------

Various Eateries PLC - London-based chain of restaurants, clubhouses and hotels such as Coppa Club - Says revenue in 2022 amounts to GBP40.7 million, up 82% from GBP22.3 million a year ago. Adjusted earnings before interest, tax, depreciation and amortisation surged to GBP3.5 million from GBP1.2 million a year ago. Pretax loss, however, widens to GBP7.2 million from GBP3.7 million, as it incurred impairments to goodwill and right of use assets of GBP2.5 million in 2022, compared to just GBP610,000 in 2021. Looking ahead, Various Eateries notes the uncertain outlook for inflationary pressures and ongoing threat of negative impact of train strikes, but says it is confident of delivering another year of progress in 2023.

----------

Benchmark Holdings PLC - West Sussex, England-based aquaculture biotechnology company - Says revenue for the first quarter ended December is GBP54.5 million, up 36% from GBP40.0 million the year before. Says Genetics division has delivered strong revenue growth of 41%, driven by "higher sales of salmon eggs and harvest revenues". Swings to pretax profit of GBP100,000 from a loss of GBP3.7 million as operating loss narrows to GBP122,000 from GBP1.5 million on higher finance income of GBP7.5 million, compared to just GBP119,000 a year earlier. Notes "encouraging" outlook for financial 2023.

-----------

Inland Homes PLC - Buckinghamshire, England-based brownfield site developer, housebuilder and regeneration specialist - Delays publication of results for financial year ended September 30 to March. In August, Inland named PricewaterhouseCoopers LLP as its new auditors. Both agree that they need additional time to finalise the accounts and related audit procedures.

-----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Reports revenue of AUD2.7 million, or GBP1.5 million for the six months ended on December 31, up slightly from AUD2.6 million a year before. ArtemiCTM sales during the period totals AUD1.50 million, representing 57% of the total revenue. Pretax loss, however, widens to AUD11.1 million from AUD8.1 million, as administrative expenses rise to AUD7.6 million from AUD4.9 million a year ago. Write off impairment expense widens to AUD3.1 million from AUD224,134.

----------

By Xindi Wei, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
17 May 2021 15:04

TRADING UPDATES: Pelatro gets contracts; Futura raises GBP10 million

TRADING UPDATES: Pelatro gets contracts; Futura raises GBP10 million

Read more
7 May 2021 19:16

IN BRIEF: MGC Pharmaceuticals gets ArtemiC trial boost

IN BRIEF: MGC Pharmaceuticals gets ArtemiC trial boost

Read more
6 May 2021 19:25

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge

Read more
4 May 2021 18:13

TRADING UPDATES: Camellia expects 2022 normality; Microsaic loss slims

TRADING UPDATES: Camellia expects 2022 normality; Microsaic loss slims

Read more
28 Apr 2021 14:04

TRADING UPDATES: Beximco's India jab mire; Lamprell gets Aramco deal

TRADING UPDATES: Beximco's India jab mire; Lamprell gets Aramco deal

Read more
27 Apr 2021 10:57

IN BRIEF: MGC Pharmaceuticals sees record sales in March

IN BRIEF: MGC Pharmaceuticals sees record sales in March

Read more
22 Apr 2021 18:33

TRADING UPDATES: Bank of Georgia wins Pipia case; MGC buys MediCaNL

TRADING UPDATES: Bank of Georgia wins Pipia case; MGC buys MediCaNL

Read more
7 Apr 2021 15:26

IN BRIEF: MGC quarterly revenue jumps on ArtemiC Rescue order delivery

IN BRIEF: MGC quarterly revenue jumps on ArtemiC Rescue order delivery

Read more
24 Mar 2021 15:56

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
22 Mar 2021 13:44

IN BRIEF: MGC Pharmaceuticals to conduct CimetrA trial in Israel

IN BRIEF: MGC Pharmaceuticals to conduct CimetrA trial in Israel

Read more
2 Mar 2021 17:12

TRADING UPDATES: Marlowe executes strategy with whirl of acquisitions

TRADING UPDATES: Marlowe executes strategy with whirl of acquisitions

Read more
26 Feb 2021 11:53

MGC Pharmaceuticals Loss Narrows In First Half On Reduced Costs

MGC Pharmaceuticals Loss Narrows In First Half On Reduced Costs

Read more
24 Feb 2021 09:54

Fragrant Prosperity Shares Rise On Expansion Into Medicinal Cannabis

Fragrant Prosperity Shares Rise On Expansion Into Medicinal Cannabis

Read more
18 Feb 2021 12:15

TRADING UPDATES: Supermarket REIT Ups Stake In Sainsbury's Portfolio

TRADING UPDATES: Supermarket REIT Ups Stake In Sainsbury's Portfolio

Read more
15 Feb 2021 11:44

IN BRIEF: MGC Pharma Starts Oral Cannabis Study To Treat Brain Tumours

IN BRIEF: MGC Pharma Starts Oral Cannabis Study To Treat Brain Tumours

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.